Davis Foote

Title: Innovations by Davis Foote in Prostate Cancer Prediction

Introduction

Davis Foote is an innovative inventor based in Mountain View, CA. He has made significant contributions to the field of artificial intelligence, particularly in the medical domain. His work focuses on improving the prediction of prostate cancer outcomes through advanced AI techniques.

Latest Patents

Davis Foote holds a patent for an innovative method titled "Artificial intelligence prediction of prostate cancer outcomes." This method involves receiving an image of prostate tissue and assigning Gleason pattern values to specific regions within the image using an AI Gleason grading model. The model is trained to identify Gleason patterns on a patch-by-patch basis in a prostate tissue image. The process includes determining relative areal proportions of the Gleason patterns within the image, assigning a risk score or risk group value based on these proportions, and outputting the risk score or risk group value. This patent represents a significant advancement in the use of AI for medical diagnostics, with the potential to improve patient outcomes.

Career Highlights

Davis Foote is currently employed at Verily Life Sciences LLC, a company dedicated to using technology to improve healthcare. His work at Verily focuses on integrating artificial intelligence into medical practices, particularly in oncology. With a patent portfolio that includes 1 patent, he is recognized for his contributions to the field.

Collaborations

Davis has collaborated with notable colleagues such as Craig Mermel and Yun Liu. Their combined expertise enhances the innovative projects they undertake at Verily Life Sciences LLC.

Conclusion

Davis Foote's work in artificial intelligence and prostate cancer prediction exemplifies the intersection of technology and healthcare. His innovative approach has the potential to transform medical diagnostics and improve patient care.